• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于人工智能的视网膜前膜手术成像生物标志物评估

Artificial intelligence-based assessment of imaging biomarkers in epiretinal membrane surgery.

作者信息

Mariotti Cesare, Mangoni Lorenzo, Muzi Alessio, Fella Michele, Mogetta Veronica, Bongiovanni Giacomo, Rizzo Clara, Chhablani Jay, Midena Edoardo, Lupidi Marco

机构信息

Eye Clinic, Department of Experimental and Clinical Medicine, Polytechnic University of Marche, Ancona, Italy.

Department of Ophthalmology, Humanitas Gradenigo, Turin, Italy.

出版信息

Eur J Ophthalmol. 2025 Sep;35(5):1542-1553. doi: 10.1177/11206721251337139. Epub 2025 Apr 27.

DOI:10.1177/11206721251337139
PMID:40289523
Abstract

PurposeThis study investigated the applicability of a validated AI-algorithm for analyzing different retinal biomarkers in eyes affected by epiretinal membranes (ERMs) before and after surgery.MethodsA retrospective study included 40 patients surgically treated for ERMs removal between November 2022 and January 2024. Pars plana vitrectomy with ERM/ILM peeling was performed by a single experienced surgeon. A validated AI algorithm was used to analyze OCT scans, focusing on intraretinal fluid (IRF) and subretinal fluid (SRF) volumes, external limiting membrane (ELM) and ellipsoid zone (EZ) interruption percentages and hyper-reflective foci (HRF) counts.ResultsPostoperative best corrected visual acuity (BCVA) significantly improved ( < 0.01), and central macular thickness (CMT) decreased from 483.61 ± 96.32 to 386.82 ± 94.86 µm ( = 0.001). IRF volume reduced from 0.283 ± 0.39 mm to 0.142 ± 0.27 mm ( = 0.036) particularly in the central 1 mm-circle. SRF, HRF and EZ/ELM interruption percentages exhibited no significant differences ( > 0.05). Significant correlations ( < 0.05) were found between preoperative BCVA and postoperative BCVA ( = 0.45); CMT reduction and postoperative BCVA ( = 0.42), preoperative IRF and Visual Recovery ( = -0.48), ELM and EZ interruption and visual recovery ( = -0.43 and  = -0.47 respectively). Multivariate analysis demonstrated that fluid distribution, especially in the central subfield, correlated with BCVA recovery (R2 = 0.38;  < 0.05; Pillai's Trace = 0.79).ConclusionThe study highlights AI's potential in quantifying OCT biomarkers in ERMs surgery. The findings suggest that improved BCVA is associated with reduced CMT, IRF, and redistribution of IRF towards the periphery. EZ and ELM integrities remain crucial prognostic factors, emphasizing the importance of the preoperative analysis.

摘要

目的

本研究调查了一种经过验证的人工智能算法在分析视网膜前膜(ERM)手术前后受影响眼睛中不同视网膜生物标志物的适用性。

方法

一项回顾性研究纳入了2022年11月至2024年1月期间接受ERM切除术的40例手术患者。由一位经验丰富的外科医生进行玻璃体视网膜切除术联合ERM/内界膜(ILM)剥除术。使用经过验证的人工智能算法分析光学相干断层扫描(OCT),重点关注视网膜内液(IRF)和视网膜下液(SRF)体积、外界膜(ELM)和椭圆体带(EZ)中断百分比以及高反射灶(HRF)计数。

结果

术后最佳矫正视力(BCVA)显著改善(<0.01),中心黄斑厚度(CMT)从483.61±96.32μm降至386.82±94.86μm(=0.001)。IRF体积从0.283±0.39mm降至0.142±0.27mm(=0.036),尤其是在中央1mm圆内。SRF、HRF以及EZ/ELM中断百分比无显著差异(>0.05)。术前BCVA与术后BCVA之间存在显著相关性(<0.05)(=0.45);CMT降低与术后BCVA之间存在显著相关性(=0.42),术前IRF与视力恢复之间存在显著相关性(= -0.48),ELM和EZ中断与视力恢复之间存在显著相关性(分别为= -0.43和= -0.47)。多因素分析表明,液体分布,尤其是在中央子区域,与BCVA恢复相关(R2 = 0.38;<0.05;Pillai迹= 0.79)。

结论

该研究突出了人工智能在量化ERM手术中OCT生物标志物方面的潜力。研究结果表明,BCVA改善与CMT降低、IRF减少以及IRF向周边重新分布有关。EZ和ELM完整性仍然是关键的预后因素,强调了术前分析的重要性。

相似文献

1
Artificial intelligence-based assessment of imaging biomarkers in epiretinal membrane surgery.基于人工智能的视网膜前膜手术成像生物标志物评估
Eur J Ophthalmol. 2025 Sep;35(5):1542-1553. doi: 10.1177/11206721251337139. Epub 2025 Apr 27.
2
Idiopathic epiretinal membrane surgery with internal limiting membrane peeling: An optical coherence tomography angiography analysis of macular capillary plexus changes.特发性视网膜前膜手术联合内界膜剥除术:黄斑毛细血管丛变化的光学相干断层扫描血管造影分析
Eur J Ophthalmol. 2025 Jul;35(4):1394-1401. doi: 10.1177/11206721241304139. Epub 2024 Dec 19.
3
Evaluation of the Efficacy and Safety of Preoperative Intravitreal Triamcinolone Acetonide Combined with Internal Limiting Membrane Peeling for the Treatment of Idiopathic Macular Epiretinal Membrane.术前玻璃体内注射曲安奈德联合内界膜剥除术治疗特发性黄斑视网膜前膜的疗效及安全性评估
Semin Ophthalmol. 2025 Jul;40(5):426-432. doi: 10.1080/08820538.2025.2463999. Epub 2025 Feb 7.
4
Retinal Fluid and Thickness Fluctuations in Archway Trial for Port Delivery System with Ranibizumab versus Monthly Ranibizumab Injections.雷珠单抗经端口递送系统与每月注射雷珠单抗的拱道试验中的视网膜液和厚度波动
Ophthalmol Retina. 2025 Apr;9(4):330-342. doi: 10.1016/j.oret.2024.10.015. Epub 2024 Oct 22.
5
SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY INSIGHTS INTO IDIOPATHIC EPIRETINAL MEMBRANE SURGERY OUTCOMES.频域光学相干断层扫描对特发性视网膜前膜手术结果的见解
Retina. 2025 Jan 1;45(1):14-22. doi: 10.1097/IAE.0000000000004258.
6
EFFECTS OF INTERNAL LIMITING MEMBRANE PEELING COMBINED WITH REMOVAL OF IDIOPATHIC EPIRETINAL MEMBRANE: A Systematic Review of Literature and Meta-Analysis.内界膜剥除联合特发性视网膜前膜去除术的效果:文献系统评价与荟萃分析
Retina. 2017 Oct;37(10):1813-1819. doi: 10.1097/IAE.0000000000001537.
7
Prognostic Features of Preoperative OCT in Retinal Detachments: A Systematic Review and Meta-analysis.术前 OCT 在视网膜脱离中的预后特征:系统评价和荟萃分析。
Ophthalmol Retina. 2023 May;7(5):383-397. doi: 10.1016/j.oret.2022.11.011. Epub 2022 Nov 24.
8
Vitrectomy in Small idiopathic MAcuLar hoLe (SMALL) study: conventional internal limiting membrane peeling versus inverted flap.特发性小马拉孔玻璃体内切除术(SMALL)研究:常规内界膜剥离与反转瓣。
Eye (Lond). 2024 Dec;38(17):3334-3340. doi: 10.1038/s41433-024-03301-z. Epub 2024 Aug 24.
9
Surgery for epiretinal membrane using three different surgical platforms: A comparative pilot study.使用三种不同手术平台治疗视网膜前膜的比较性初步研究。
Rom J Ophthalmol. 2025 Jan-Mar;69(1):53-59. doi: 10.22336/rjo.2025.10.
10
Pars plana vitrectomy with ILM peeling for macular edema of various etiologies: results from the SCRV macula surgery study.采用内界膜剥除术的玻璃体切除术治疗各种病因引起的黄斑水肿:SCRV黄斑手术研究结果
Int Ophthalmol. 2025 Aug 25;45(1):352. doi: 10.1007/s10792-025-03721-0.